|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ji X, Cai J, Chen Y and Chen LQ: Lymphatic
spreading and lymphadenectomy for esophageal carcinoma. World J
Gastrointest Surg. 8:90–94. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wilusz CJ, Wormington M and Peltz SW: The
cap-to-tail guide to mRNA turnover. Nat Rev Mol Cell Biol.
2:237–246. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pont AR, Sadri N, Hsiao SJ, Smith S and
Schneider RJ: mRNA decay factor AUF1 maintains normal aging,
telomere maintenance, and suppression of senescence by activation
of telomerase transcription. Mol Cell. 47:5–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gruber AR, Fallmann J, Kratochvill F,
Kovarik P and Hofacker IL: AREsite: A database for the
comprehensive investigation of AU-rich elements. Nucleic Acids Res.
39(Database): D66–D69. 2011. View Article : Google Scholar :
|
|
7
|
White EJ, Brewer G and Wilson GM:
Post-transcriptional control of gene expression by AUF1:
Mechanisms, physiological targets, and regulation. Biochim Biophys
Acta. 1829:680–688. 2013. View Article : Google Scholar :
|
|
8
|
Gratacós FM and Brewer G: The role of AUF1
in regulated mRNA decay. Wiley Interdiscip Rev RNA. 1:457–473.
2010. View
Article : Google Scholar
|
|
9
|
Barker A, Epis MR, Porter CJ, Hopkins BR,
Wilce MC, Wilce JA, Giles KM and Leedman PJ: Sequence requirements
for RNA binding by HuR and AUF1. J Biochem. 151:423–437. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moore AE, Chenette DM, Larkin LC and
Schneider RJ: Physiological networks and disease functions of
RNA-binding protein AUF1. Wiley Interdiscip Rev RNA. 5:549–564.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Abdelmohsen K, Tominaga-Yamanaka K,
Srikantan S, Yoon JH, Kang MJ and Gorospe M: RNA-binding protein
AUF1 represses Dicer expression. Nucleic Acids Res. 40:11531–11544.
2012.PubMed/NCBI
|
|
12
|
Kumar M, Matta A, Masui O, Srivastava G,
Kaur J, Thakar A, Shukla NK, RoyChoudhury A, Sharma M, Walfish PG,
et al: Nuclear heterogeneous nuclear ribonucleoprotein D is
associated with poor prognosis and interactome analysis reveals its
novel binding partners in oral cancer. J Transl Med. 13:2852015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gouble A, Grazide S, Meggetto F, Mercier
P, Delsol G and Morello D: A new player in oncogenesis: AUF1/hnRNPD
over-expression leads to tumorigenesis in transgenic mice. Cancer
Res. 62:1489–1495. 2002.PubMed/NCBI
|
|
14
|
von Roretz C, Di Marco S, Mazroui R and
Gallouzi IE: Turnover of AU-rich-containing mRNAs during stress: A
matter of survival. Wiley Interdiscip Rev RNA. 2:336–347. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lapucci A, Donnini M, Papucci L, Witort E,
Tempestini A, Bevilacqua A, Nicolin A, Brewer G, Schiavone N and
Capaccioli S: AUF1 is a bcl-2 A + U-rich element-binding protein
involved in bcl-2 mRNA destabilization during apoptosis. J Biol
Chem. 277:16139–16146. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin S, Wang W, Wilson GM, Yang X, Brewer
G, Holbrook NJ and Gorospe M: Down-regulation of cyclin D1
expression by prostaglandin A2 is mediated by enhanced
cyclin D1 mRNA turnover. Mol Cell Biol. 20:7903–7913. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Luo J, Zhou X, Ge X, Liu P, Cao J, Lu X,
Ling Y and Zhang S: Upregulation of Ying Yang 1 (YY1) suppresses
esophageal squamous cell carcinoma development through heme
oxygenase-1. Cancer Sci. 104:1544–1551. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sobin LH and Wittekind C: TNM
Classification of Malignant Tumor. 6. John Wiley and Sons; New
Jersey: 2002
|
|
19
|
Thöny B, Auerbach G and Blau N:
Tetrahydrobiopterin biosynthesis, regeneration and functions.
Biochem J. 347:1–16. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Werner ER, Blau N and Thöny B:
Tetrahydrobiopterin: Biochemistry and pathophysiology. Biochem J.
438:397–414. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen L, Zeng X, Kleibeuker E, Buffa F,
Barberis A, Leek RD, Roxanis I, Zhang W, Worth A, Beech JS, et al:
Paracrine effect of GTP cyclohydrolase and angiopoietin-1
interaction in stromal fibroblasts on tumor Tie2 activation and
breast cancer growth. Oncotarget. 7:9353–9367. 2016.PubMed/NCBI
|
|
22
|
Trojanowicz B, Brodauf L, Sekulla C,
Lorenz K, Finke R, Dralle H and Hoang-Vu C: The role of AUF1 in
thyroid carcinoma progression. Endocr Relat Cancer. 16:857–871.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zucconi BE and Wilson GM: Modulation of
neoplastic gene regulatory pathways by the RNA-binding factor AUF1.
Front Biosci (Landmark Ed). 16:2307–2325. 2011. View Article : Google Scholar
|
|
24
|
Vázquez-Chantada M, Fernández-Ramos D,
Embade N, Martínez-Lopez N, Varela-Rey M, Woodhoo A, Luka Z, Wagner
C, Anglim PP, Finnell RH, et al: HuR/methyl-HuR and AUF1 regulate
the MAT expressed during liver proliferation, differentiation, and
carcinogenesis. Gastroenterology. 138:1943–1953. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Antoniades C, Shirodaria C, Van Assche T,
Cunnington C, Tegeder I, Lötsch J, Guzik TJ, Leeson P, Diesch J,
Tousoulis D, et al: GCH1 haplotype determines vascular and plasma
biopterin availability in coronary artery disease effects on
vascular super-oxide production and endothelial function. J Am Coll
Cardiol. 52:158–165. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Douglas G, Hale AB, Crabtree MJ, Ryan BJ,
Hansler A, Watschinger K, Gross SS, Lygate CA, Alp NJ and Channon
KM: A requirement for Gch1 and tetrahydrobiopterin in embryonic
development. Dev Biol. 399:129–138. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ying L and Hofseth LJ: An emerging role
for endothelial nitric oxide synthase in chronic inflammation and
cancer. Cancer Res. 67:1407–1410. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Loibl S, von Minckwitz G, Weber S, Sinn
HP, Schini-Kerth VB, Lobysheva I, Nepveu F, Wolf G, Strebhardt K
and Kaufmann M: Expression of endothelial and inducible nitric
oxide synthase in benign and malignant lesions of the breast and
measurement of nitric oxide using electron paramagnetic resonance
spectroscopy. Cancer. 95:1191–1198. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thomsen LL, Miles DW, Happerfield L,
Bobrow LG, Knowles RG and Moncada S: Nitric oxide synthase activity
in human breast cancer. Br J Cancer. 72:41–44. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Beevi SS, Rasheed MH and Geetha A:
Evidence of oxidative and nitrosative stress in patients with
cervical squamous cell carcinoma. Clin Chim Acta. 375:119–123.
2007. View Article : Google Scholar
|
|
31
|
Masri FA, Comhair SA, Koeck T, Xu W,
Janocha A, Ghosh S, Dweik RA, Golish J, Kinter M, Stuehr DJ, et al:
Abnormalities in nitric oxide and its derivatives in lung cancer.
Am J Respir Crit Care Med. 172:597–605. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Feng CW, Wang LD, Jiao LH, Liu B, Zheng S
and Xie XJ: Expression of p53, inducible nitric oxide synthase and
vascular endothelial growth factor in gastric precancerous and
cancerous lesions: Correlation with clinical features. BMC Cancer.
2:82002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cooper RG and Magwere T: Nitric
oxide-mediated pathogenesis during nicotine and alcohol
consumption. Indian J Physiol Pharmacol. 52:11–18. 2008.PubMed/NCBI
|
|
34
|
Chen L, Zeng X, Wang J, Briggs SS, O'Neill
E, Li J, Leek R, Kerr DJ, Harris AL and Cai S: Roles of
tetrahydrobiopterin in promoting tumor angiogenesis. Am J Pathol.
177:2671–2680. 2010. View Article : Google Scholar : PubMed/NCBI
|
